Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages
Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...
Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma
Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.
Targeted Oncology1d
Fellow's Perspective: Patient Case of Newly Diagnosed Multiple Myeloma
Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...
Military.com1d
VA Set to Add Leukemia, Multiple Myeloma to List of Conditions Linked to Burn Pits
The department used its new system for determining whether a condition is service-connected to give affected veterans access ...
Cure Today2d
FDA Receives Application Seeking Approval of Darzalex Faspro in Smoldering Myeloma
If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.
Pharmabiz3d
Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma
Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma: Raritan, New Jersey Monday, November ...
Hosted on MSN4d
Opinion: Myeloma Explained — Insights Into The Disease And Its Treatment
Multiple Myeloma is a type of blood cancer that develops in plasma cells — white blood cells responsible for producing ...
Business Wire6d
Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with ...